Various valved conduits and stent-mounted valves are used for right ventricular outflow tract (RVOT) valve replacement in patients with congenital heart disease. When using prosthetic materials however, these grafts are susceptible to bacterial infections and various host responses.
Introduction
Staphylococcus aureus (S. aureus) employs a variety of virulence strategies to circumvent the host immune defense system colonizing biological or non-biological surfaces implanted in the human circulation, which leads to severe intravascular infections such as sepsis and IE 1, 2, 3, 4, 5 . IE remains an important treatment associated complication in patients after implantation of prosthetic heart valves while individual factors contributing to the onset of IEare not yet fully understood 6, 7 . Under flow conditions, bacteria encounter shear forces, which they need to overcome in order to adhere to the vessel wall 8 . Models, which allow studying the interplay between bacteria and prosthetic valve tissue or endothelium under flow, are of interest as they reflect the in vivo situation more.
Several specific mechanisms facilitate bacterial adherence to endothelial cells (ECs) and to the exposed subendothelial matrix (ECM) leading to tissue colonization and maturation of vegetations, being essential early steps in IE 9 . Various staphylococcal surface proteins or MSCRAMMs (microbial surface components recognizing adhesive matrix molecules) have been described as mediators of adhesion to host cells and to ECM proteins by interacting with molecules such as fibronectin, fibrinogen, collagen and von Willebrand factor (VWF) 8, 10, 11 . However, in view of intra-molecular folding of some virulence factors, mostly studied in static conditions, many of these interactions may have different relevance in endovascular infections in circulating blood.
Therefore, we present an in-house designed in vitro parallel-plate flow chamber model, which allows the assessment of bacterial adherence to different components of ECM and ECs in the context of tissue grafts implanted in the RVOT position. The overall purpose of the method described in this work is to study mechanisms of interaction between bacteria and underlying endovascular tissues in flow conditions, which are 5. After perfusion, dismantle the chamber to release the graft and wash the tissue piece two times with 4 mL of PBS in a 12-well plate using the laboratory orbital shaker for 3 min each. Subsequently cut the inner part of the graft using a skin biopsy punch of a smaller diameter. 6. Place each tissue biopsy into a separate 14 mL tube containing 1 mL of sterile 0.9% NaCl. Label the tube as #1. 7. Detach the bacteria from the tissue using a sonication bath for 10 min (amplitude = 100% and frequency = 45 kHz).
Note: Full detachment of bacteria from the tissue grafts should be evaluated upon incubation of patches overnight at 37 °C in TSB liquid medium followed by OD 600 measurements compared to control patches treated with a bacteria free solution. 8. Use a serial dilution method on Mueller-Hinton blood agar plates to count CFUs.
1. Prepare a single 14 mL tube with 10 mL of sterile saline to make serial dilutions of the bacterial suspension obtained after sonication. Label this tube as #2. Note: For each tissue experiment one tube with 10 mL of 0.9% NaCl is necessary. 2. Prepare three 14 mL tubes with 10 mL of sterile 0.9% NaCl for serial dilutions of initial bacterial suspension from step 2.7. Label the tubes as follows #3, #4, #5. Note: This step is necessary to know the real CFU number in bacterial suspension used for the perfusion experiment. 3. Vortex mix each tube for 15 s. Vortex the tubes with the tissue biopsy as well as the initial bacterial suspension to make serial dilutions. 4. Prepare three agar plates, two for the tissue experiment (perfusion of bacteria and control perfusion of PBS) and the third one for the initial bacterial suspension used for perfusions. , repeat this step 4 times to obtain 4 separate growths from each volume of 10 µL. Note: Due to the small volume used for plating onto the sector 10 -4 , it is advised to have multiple number of droplets to make an average number of grown CFUs. 8. To prepare the serial dilutions of the initial culture, transfer 100 µL of bacterial suspension from step 2.7 to tube #3 and mix vigorously with vortex. Add 100 µL of tube #3 to tube #4 and mix well, repeat the procedure for subsequent tube #5. 9. Spread 100 µL of the contents of tubes #3, #4, #5 and the adjusted bacterial suspension (step 2.7), respectively, onto sectors 10 
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1. After perfusion, wash tissue pieces with PBS (see step 3.5) and cut the inner part of a graft using a punch of a smaller diameter.
2. Prepare a 6-well plate and place droplets of mounting medium (Table of Materials) .
3. Place each piece of tissue with its perfused surface downward on a single drop of mounting medium. 4. Read a plate using a fluorescence scanner (Table of Materials) . Set parameters of excitation and emission wavelengths according to a fluorophore used for bacterial labeling.
Representative Results
To better understand the mechanisms behind IE development, this model enables the evaluation of bacterial and tissue associated factors present in the in vivo situation of infection onset.
In detail, the novel in vitro approach allows to quantify bacterial adhesion in flow conditions to different graft tissues by perfusing fluorescently labeled bacteria over the tissues exerting the shear stresses in the physiological range of 3 -10 dyne/cm 2 for the RVOT. In this work, we used a flow rate of 4 mL/min that corresponded to 3 dyne/cm 2 . Taking into consideration the channel height of 0.3 mm across all tissue patches, the distance between the mounted graft and the medium inlet of about 39 mm, the perfusion chamber (shown in Figure 1 ) guarantees fully developed laminar flow (Re = 3.89 is significantly lower than 2000; the entrance length = 0.05 mm is significantly smaller than the distance `inletgraft`, parameters necessary for assuming appropriate flow pattern).
Under shear stress conditions, a similar bacterial attachment across the various graft tissues was observed for both S. aureus and S. epidermidis infection (Figure 2 and Figure 3) . Although not significant, a trend towards higher adhesion of S. aureus to the CH leaflets was noticeable.
For S. sanguinis a significant reduction of adherence to the BJV wall was found when compared to the BP patch (Figure 4 ; P < 0.05). When comparing the 3 species of bacteria, S. sanguinis presents significantly lower adhesion to the BJV wall in relation to S. aureus and S. epidermidis (P < 0.01 and P < 0.05 respectively, see the video). In general, we observed a similar bacterial adhesion to all tissues investigated under shear stress.
Our data from CFU counting (Figure 2, Figure 3, Figure 4 ) are supported by fluorescence microscopy using a high throughput scanner ( Figure  5, Figure 6, Figure 7) . Images are presenting pronounced foci of labeled bacteria adhering to graft tissues. Due to this approach, we were able to directly visualize tissues upon perfusion without any post experimental processing for illustration purposes. 
Discussion
Recent clinical observations give special awareness to IE as a complication in patients having undergone valve replacement of the RVOT 6, 13 . Dysfunction of the implanted valve in IE is the result of bacterial interaction with the endovascular graft leading to extensive inflammatory and procoagulant reactions 1, 14 . The presented novel in vitro model allowed us to investigate if differences in tissue structures and bacterial factors are likely to modulate the susceptibility to infections of in vivo used grafts 15 . BJV and CH graft tissue showed similar propensity towards bacterial recruitment in flow conditions. Therefore, data suggest that in general the source of the tissue and its surface structure as well as specific bacterial adhesive proteins per se are not the major determinant factors in initial bacterial adherence.
In general, pathways evoking inflammation, tissue damage, platelet and fibrin deposition at the infected endovascular site are activated by multiple players 1, 16 . A major advantage of the developed in vitro model is the opportunity to analyze stepwise the contribution of involved players. Single bacterial factors can be investigated by using bacterial mutant strains or genetically modified bacteria expressing single adhesion proteins on their surface 14 . By choosing different perfusion media, plasma or blood, the involvement of plasma proteins and blood cells can be evaluated. Further studies will focus on tissue related factors for which tissues will be pre-incubated with for example plasma proteins before mounted in the flow chamber for subsequent perfusion. Since players contributing to the onset of prosthetic valve IE remain unclear, future studies might unravel the potential factors by building up to a more complex experimental setup. Furthermore, this experimental setup inherits the possibility that tissues can be seeded with an EC layer to analyze shear-dependent EC gene expression. The parallel-plate flow chamber also allows perfusion over EC-covered microscope slides due to a flexible inner height of the perfusion chamber. Different coatings of cover slips using various extracellular matrix proteins are also a possible option to assess important interactions with the subendothelial matrix. In addition, pharmacologic inhibitors or functional antibodies can be investigated for their effect in the respective condition in our flow chamber. In summary, various conditions can be studied by increasing complexity.
Inflammatory activation at the infected area of the graft is a crucial, shear-controlled step favoring deposition of activated platelets and monocytes. The impact of shear forces on bacterial adherence to tissue surfaces are of major concern. To address this issue, the novelty of the presented in vitro system focuses on the possibility to mount tissues in a flow chamber. This reinforces the significance of the method beyond existing alternatives, in which usually static interactions between bacteria and underlying tissues have been investigated. Even though shear stress was submitted by shaking or other external forces, it has not been standardized to the same level as we can gain from our uniform flow model.
In vivo, a non-physiologic flow pattern can favor bacterial adhesion as the onset of IE at the valve level of implanted conduits. Shear stress was found to up-regulate endothelial inflammatory parameters such as cytokine secretion and to increase tissue factor mediated coagulation 17 . The interaction of the underlying tissue used for valve prostheses with bacteria and their influence on EC gene expression under shear stress is important to construct a valve less capable of bacterial adhesion and chronic inflammation.
The basal technical issues of the fabricated chamber allow investigations under standardized conditions in the laminar flow 18 . To ensure the fully developed laminar flow at the site of the investigated tissue the chamber is constructed to mount the graft in a certain distance from the medium inlet (significantly longer than the computed entrance length, see Results and Figure 1) . Using different pumps in the system would allow performing experiments under pulsatile or turbulent flow conditions in the future.
The flexible frame of the chamber prevents the chamber effectively from leaking and the internal height of the frame allows adapting for tissue thickness. The construction of the whole system enables a circulating flow, which is of importance to perform long lasting perfusions with using a respective amount of medium. Based on previous studies our adhesion protocol assumed a bacterial inoculation dose of 10 7 CFU/mL for a 1 h incubation 4, 19 Further modifications of the method will focus on more efficient consumption of medium during the procedure as well as on simplification of mounting the setup. In addition, a new design including multiple slots for tissue assembly would ease an entire experiment in aspects such as efficiency.
At this stage our method is focused on the end-point results and was not tested for real time applications such as the time course of dynamic events occurring on the tissue surface. Thus, this broader application remains under consideration; however, issues such as tissue autofluorescence, optimization of an appropriate fluorescence microscope protocol as well as adaptations of the chamber need to be addressed. Further on, the method in its current state may be adapted to real-time monitoring of bacterial binding to EC layers on microscope slides by upright fluorescence microscope. Currently, we are able to visualize bacteria and other blood components/cells bound to tissues by confocal microscopy without a need for post experimental tissue processing, which is predisposing for the real-time visualization under flow by inverted fluorescence microscopes.
In this study, the quantification of bacterial adhesion was provided by CFU counting while fluorescence microscopy was a supportive, nonquantitative tool. Due to resolution issues resulting from the lack of an adequate microscope lens, fluorescence imaging turned out to be less reproducible in our hands than serial dilutions. Nevertheless, it is possible to use fluorescence scanning for quantification when suitable objective lens could illuminate the entire graft size of 8 mm in diameter for reliable foci quantification. Using an image processing program (such as ImageJ), absolute fluorescence units might be quantified for investigated tissue specimens and the bacterial adhesion might be expressed for example as a relative signal to the internal control (grafts perfused with non-labeled bacteria).
The major limitation of this experimental setting are the issues associated with in vitro studies in general. Results reached by using this in vitro flow chamber model could be transferred to an animal model for in vivo confirmation.
In conclusion, this in vitro model allows investigation of single bacterial, tissue and shear-based factors contributing to the onset of bacterial adhesion to tissues in a stepwise manner. The hereby enabled knowledge could contribute to the development of more effective prevention and treatment of IE.
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